Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.70
(
0.00%
)
Bitcoin
78,239.17
(
0.12%
)
News Focus
News Focus
Post# of 257580
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biopearl

Send PM Follow Ignore
Followers 6
Posts 760
Boards Moderated 0
Alias Born 07/18/2006

biopearl

Re: DewDiligence post# 94781

Monday, 04/26/2010 4:58:29 PM

Monday, April 26, 2010 4:58:29 PM

Post# of 257580
Dew (or anyone else knowledgeable), given the current healthcare legislation that is now law, is there clarity regarding biosimilar, biobetter generic drug production? If not, could the FDA delay re MNTA be related to some need for legislative guidance for the agency? Thanks bp
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today